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Diabetic Csf1op/op mice do not develop delayed gastric
emptying but wild-type Csf1þ/þ mice do. This result
reinforces the concept that macrophages are necessary for
the development of delayed gastric emptying.
BACKGROUND & AIMS: Diabetic gastroparesis is associated
with changes in interstitial cells of Cajal (ICC), neurons, and
smooth muscle cells in both animal models and humans.
Macrophages appear to be critical to the development of
cellular damage that leads to delayed gastric emptying (GE),
but the mechanisms involved are not well understood. Csf1op/op
(Op/Op) mice lack biologically active Csf1 (macrophage
colony stimulating factor), resulting in the absence of Csf1-
dependent tissue macrophages. We used Csf1op/op mice to
determine the role of macrophages in the development of
delayed GE.
METHODS: Animals were injected with streptozotocin to make
them diabetic. GE was determined weekly. Immunohisto-
chemistry was used to identify macrophages and ICC networks
in the gastric muscular layers. Oxidative stress was measured
by serum malondialdehyde (MDA) levels. Quantitative reverse-
transcription polymerase chain reaction was used to measure
levels of mRNA.
RESULTS: Csf1op/op mice had normal ICC. With onset of dia-
betes both Csf1op/op and wild-type Csf1þ/þ mice developed
increased levels of oxidative stress (75.8 ± 9.1 and 41.2
± 13.6 nmol/mL MDA, respectively). Wild-type Csf1þ/þ mice
developed delayed GE after the onset of diabetes (4 of 13)
whereas no diabetic Csf1op/op mouse developed delayed GE
(0 of 15, P ¼ .035). The ICC were disrupted in diabetic wild-
type Csf1þ/þ mice with delayed GE but remained normal in
diabetic Csf1op/op mice.
CONCLUSIONS: Cellular injury and development of delayed GE
in diabetes requires the presence of muscle layer macrophages.
Targeting macrophages may be an effective therapeutic option
to prevent cellular damage and development of delayed GE in
diabetes. (Cell Mol Gastroenterol Hepatol 2016;2:40–47; http://
dx.doi.org/10.1016/j.jcmgh.2015.09.001)
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Cells of Cajal.astroparesis is a complication of diabetes deﬁned byGdelayed emptying of stomach contents in the
absence of obstruction and is frequently accompanied by
early satiety, nausea, vomiting, and pain.1–3 Recent publi-
cations have highlighted the cellular changes associated
with gastroparesis in humans4,5 and in mouse models of the
disease.6,7 These include changes to interstitial cells of Cajal
(ICC), extrinsic and enteric nerves and smooth muscle cells.8
The development of delayed gastric emptying (GE) is asso-
ciated with reduced expression of the receptor tyrosine ki-
nase, Kit, a marker for interstitial cells of Cajal,6 impairment
of ICC networks and changes in the electrical slow wave
recorded from smooth muscle cells.5,9
Macrophages originate from monocytes, play a critical
role in innate immunity and also participate in adaptive im-
munity.10,11 Release of cytokines from polarized macro-
phages can both increase inﬂammation as well as play
important anti-inﬂammatory roles.10 Resident macrophages
are present in the muscle layers of the gastrointestinal
tract.12,13 They can be polarized in response to changes in the
microenvironment. Polarized macrophages in mice may be
classiﬁed in two main groups: the proinﬂammatory, classi-
cally activated macrophages (M1) and anti-inﬂammatory,
alternatively activated macrophages (M2).11 Polarization
results in a change in their phenotype and their physiology,
including alterations in the expression of surface proteins
and the production of speciﬁc cytokines.10,11
Macrophages appear to play an important role in the
development of delayedGE in both diabeticmice andhumans.
CD206 positiveM2macrophages expressing heme oxygenase
1 (HO1) are critical to the prevention of development of
delayed GE in diabetic mice and induction of HO1 in macro-
phages leads to reversal of the delay in GE.6 In humans the
Figure 1. Experimental plan used for the different groups
of mice. (A) Starting at 8 weeks old, female Csf1þ/þ wild-type
(WT) mice were trained, and two baseline gastric emptying
(GE) readings (arrows) were obtained before the mice were
treated with streptozotocin starting at 12 weeks (arrowhead).
Only mice weighing more than 20 g were used. After devel-
opment of diabetes, when the mice were 12–14 weeks old, GE
was measured weekly for up to 8 weeks. Tissues were
collected from three groups of Csf1þ/þmice: (1) diabetic mice
that develop delayed GE indicated by t1/2 values outside the
normal range on 2 consecutive weeks, (2) mice with normal GE
matched to the mice with delayed GE by duration of diabetes,
and (3) resistant mice that did not develop delayed GE after
8 weeks of diabetes. (B) Sibling Csf1op/op (Op/Op) mice un-
derwent the same regimen. These mice did not develop
delayed GE, and they were killed for tissue and blood collec-
tion after 8 weeks of diabetes (20–22 weeks of age). Csf1op/op
(Op/Op) without diabetes were observed for the same period
of time and used as controls (20–22 weeks of age).
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the number of ICC which in turn correlates with GE.14 The
exact role of macrophages in the development of delayed GE
during diabetes is still not known. For example, it remains
unclear whether it is the presence of a particular subtype (ie,
M1 macrophages) versus the absence of a subtype (ie, M2
macrophages) that leads to development of delay in GE.
Mice homozygous for the naturally occurring Csf1op
(osteopetrosis, op) gene mutation lack functional macro-
phage-colony stimulating factor (Csf1, also known asMCSF or
Csfm)15 and are deﬁcient in Csf1-dependent macrophages.
Because previous studies have shown the absence of mac-
rophages from the muscle layers of the small intestine of
Csf1op/opmice,12 they offer the opportunity to understand the
role of macrophages in the development of GE in diabetes.
Materials and Methods
Experiments were performed in accordance with the Na-
tional Institutes of Health Guide for the Care and Use of Labo-
ratory Animals. All protocols were approved by the
Institutional Animal Care and Use Committee of the Mayo
Clinic.
Animals and in Vivo Experimentation
The experimental plan is summarized in Figure 1. Mice
heterozygous for a loss of function mutation in the Csf1 gene
were obtained from the Jackson Laboratory (Bar Harbor, ME;
strain: B6; C3Fe a/a-Csf1op/J, cat. no. 000231). The osteo-
petrosis (Csf1op)mutation is a single base pair insertion in the
coding region of the Csf1 gene that generates a stop codon
21 base pair downstream of the insertion.15 Detection of
wild-type (WT) Csf1þ/þ and heterozygous animals by Sanger
sequencing of polymerase chain reaction (PCR) products was
performed by Laragen (Culver City, CA). Homozygous Csf1op/op
mice were distinguished from their normal littermates
phenotypically at 10–15 days of age by the absence of incisor
eruption. Due to the lack of teeth, Csf1op/op pups were started
on a liquid diet at 3–4 weeks of age and were weaned from
the mother at 5–6 weeks of age. These mice were maintained
until they were up to 6 months old by the use of a specialized
wet diet (Bio-Serv, Frenchtown, NJ).
WT Csf1þ/þ and Csf1op/op mice were treated with a single
injection of streptozotocin (160 mg/kg) at 12 weeks of age
to make them diabetic. The mice that did not become dia-
betic after 1 week received up to two further injections of
streptozotocin spaced a week apart. Using this regimen, all
WT Csf1þ/þ mice became diabetic (deﬁned as blood glucose
>250 mg/dL). Mice weighing less than 20 g at 12 weeks old
were not used in this study. Starting 4 days after induction,
blood glucose levels were measured daily. Subtherapeutic
insulin (Lantus insulin glargine; Sanoﬁ-Aventis U.S.,
Bridgewater, NJ) was injected once a day intraperitoneally
when the glucose levels were over 500 mg/dL to keep the
diabetic mice alive and but to still keep blood glucose levels
between 400 and 600 mg/dL in order for complications of
diabetes to develop. Oxidative stress was measured by
determining malondialdehyde (MDA) levels in the plasma as
previously described elsewhere6 using a commercial kit todetect thiobarbituric acid reactive substances (Oxi-Tek;
Zeptometrix, Buffalo, NY).
Gastric emptying of solids (cooked egg yolk) was
measured after an overnight fast using a 13[C]-octanoic acid
breath test as described previously elsewhere.16 Csf1op/op
mice required more training than WT Csf1þ/þ mice due to
their lack of teeth. However, by preparing the egg meal to be
a soft consistency, the majority of animals could be trained
to eat it within 5 minutes of being offered the meal. Because
Csf1op/op mice do not have teeth, they were fed with less
scrambled cooked egg yolk (100 mg) than used for the
Csf1þ/þ mice (200 mg). If the mice did not eat >50% of the
egg meal after 3 weeks of training, they were removed from
the study. Four baseline values for GE half-time (t1/2) were
obtained before the delivery of streptozotocin. After the
onset of diabetes, GE was measured weekly.Dissection of Tissue
The mice were killed with an overdose of carbon dioxide.
The stomach was cut along the lesser curvature, and the
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smoothmuscle layer of the body and antrum for experiments.
Immunohistochemistry
The antibodies used were a rat monoclonal raised
against the mouse F4/80 epitope conjugated to Alexa Fluor
488 (cat. no. MF48020; Life Technologies, Grand Island, NY),
and a rat monoclonal raised against mouse Kit, ACK2 (cat.
no. 14-1172-85; eBioscience, San Diego, CA). The immuno-
histochemical procedures used for each cell type are sum-
marized herein.
Macrophages
Macrophages were identiﬁed using a modiﬁcation of a
previously published ﬂuorescence immunolabeling tech-
nique.7 Freshly dissected tissues were incubated in F4/80
antibody Alexa Fluor 488 conjugate diluted to 0.4 mg/mL
with Ca2þ-containing HEPES-buffered physiologic salt so-
lution containing 135 mM NaCl, 5 mM KCl, 2 mM CaCl2,
1.2 mM MgCl2, 10 mM glucose, and 10 mM HEPES, adjusted
to pH 7.4 with Tris and incubated at 37C for 1 hour in the
dark. The tissue was then ﬁxed in 4% paraformaldehyde in
0.1 M phosphate buffer. After the tissue was rinsed in 0.1 M
phosphate-buffered saline (PBS) then water, the nuclei in
the tissue were stained by incubating the tissue for 30 mi-
nutes at 4C with 0.3 mM 406-diamidino-2-phenylindole
dihydrochloride (DAPI) (Molecular Probes, Eugene, OR) in
water.
Interstitial Cells of Cajal
After ﬁxation by immersion in cold acetone for 15 mi-
nutes, ICC were detected by use of an anti-Kit antibody
(ACK2). The tissue was washed three times in 0.1 M PBS
then blocked in 10% normal donkey serum (NDS) in PBS
and 0.3% Triton overnight at 4C. The Kit antibody (1.7 mg/
mL) was applied by incubation in 5% NDS/PBS/0.3% Triton
for 2 days at 4C. After rinsing in PBS, donkey anti-rat IgG
conjugated to ﬂuorescein (3 mg/mL; Chemicon, Temecula,
CA) was added in 2.5% NDS/PBS/0.3% Triton and incu-
bated overnight at 4C in the dark. After rinsing in PBS then
water, nuclei in the tissue were stained by incubating the
tissue for 30 minutes at 4C with 0.3 mM 406-diamidino-2-
phenylindole dihydrochloride (DAPI) in water.
Confocal Microscopy for Kit-Positive Interstitial
Cells of Cajal and Assessment and Quantiﬁcation
of Kit Immunoreactivity
Labeled tissues were examined with a laser scanning
confocal microscope using a 20 (NA 0.95) XLUMPlanFl
objective (Olympus Japan) in Fluoview (Olympus Japan)
using the optimal confocal aperture to give a resolution of
0.994  0.994  1.13 mm (X  Y  Z). Stacks of confocal
images across the full thickness of the muscularis propria
were collected from three nondiabetic Csf1op/op mice (20–22
weeks old), three diabetic Csf1op/op mice (20–22 weeks old),
three nondiabetic Csf1þ/þ mice (20–22 weeks old), and
three diabetic Csf1þ/þ with normal GE and 3 diabetic Csf1þ/þwith delayed GE mice (2, 3, and 4.6 weeks after onset of
diabetes). Six images from the gastric body and three from
the antrum were taken for each animal. For quantiﬁcation of
the labeling, all of the confocal image stacks were ﬂattened
into projections using the FV10-ASW Viewer (Olympus). The
ﬂattened images were renumbered in random order and
then assessed by scoring the integrity of the ICC on a 10-cm
visual analogue scale for network density. Scoring was done
in random order by two independent investigators blind to
the image and tissue source.
Real-Time Quantitative Reverse-Transcription
Polymerase Chain Reaction
RNA extracted from gastric muscularis propria of Csf1op/
op and wild-type Csf1þ/þ mice were used for this real-time
quantitative reverse-transcription polymerase chain reac-
tion (qRT-PCR). RNA extraction was done with RecoverAll
(Ambion, Austin, TX) according to the manufacturer’s in-
structions. The SuperScript VILO cDNA Synthesis Kit (Invi-
trogen, Carlsbad, CA) was used to generate cDNA from
extracted RNA and qRT-PCR was performed on cDNA using
commercial primer sets and RT2SYBR Green/ROX qRT-PCR
master mix according to the manufacturer’s instructions
(SABiosciences, Frederick, MD). The data were normalized
to the expression of actin, a housekeeping gene, by trans-
forming the difference in threshold cycle (DCt) to the ratio
of the gene of interest to the housekeeping gene (2DCt),17
and expressed as the mean ± standard error of the mean
(SEM) for six animals of each group.
Statistical Analysis
The statistical methods used were unpaired t tests and
one-way analysis of variance (ANOVA) with post-test ad-
justments for multiple comparisons. P < .05 was considered
statistically signiﬁcant. All authors had access to the study
data and reviewed and approved the ﬁnal manuscript.
Results
The gastric muscularis propria of WT Csf1þ/þ mice was
densely populated with macrophages as detected by F4/80
immunoreactivity (Figure 2A). These cells had a character-
istic morphology with several ﬂattened pseudopodia that
branched from the main axis of the cell. However, no F4/80-
positive macrophages were found in the muscle layers from
the stomach of Csf1op/op mice before or after the develop-
ment of diabetes (see Figure 2B and C). Before the devel-
opment of diabetes, the Csf1op/op mice were smaller in size
when compared with the WT Csf1þ/þ mice (see Figure 2D;
WT 25.11 ± 3.72, Op/Op 21.92 ± 2.23 g; P < .05, unpaired t
test).
The blood glucose values in nondiabetic mice did not
differ between the groups (Figure 3A; WT 117 ± 16, Op/Op
106 ± 18 mg/dL; P ¼ not statistically signiﬁcant [NS], one-
way ANOVA with Tukey’s post-test). After treatment with
streptozotocin to induce diabetes, the diabetic mice had
similar elevated nonfasting blood glucose levels regardless
of whether they were WT Csf1þ/þ or Csf1op/op (see
Figure 3A; WT 410.89 ± 62.79, Op/Op 342.15 ± 67.94;
Figure 2. Csf1op/op mice lack macrophages in the gastric muscularis propria. (A) Resident macrophages in the muscularis
propria of wild-type (WT) Csf1þ/þ mice. Whole-mount preparations from the murine stomach were labeled with the F4/80
antibody. Csf1op/op mice lack macrophages in the gastric muscularis propria when (B) not diabetic and (C) 8 weeks after the
development of diabetes. Scale bar: 50 mm for each image. Age of mice: 20–22 weeks. (D) Weight of WT Csf1þ/þ and Csf1op/op
(Op/Op) mice before the development of diabetes. The circles represent individual animals. Csf1þ/þ (WT) were heavier than
Csf1op/op (Op/Op) at the beginning of the experiment. Data are represented as mean ± standard error of the mean. aP < .05,
unpaired t test. Age of mice: 12–14 weeks.
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groups of mice received similar levels of insulin to maintain
blood glucose <600 mg/dL after the onset of diabetes (WT
3.98 ± 0.57, Op/Op 5.77 ± 1.55 unit/week; P ¼ NS, t test).
Normal GE values for Csf1op/op mice had not been pre-
viously reported, so we determined the normal ranges for
GE times in Csf1op/op and WT Csf1þ/þ mice in separate co-
horts. The normal range was deﬁned as between the 2.5th
and 97.5th percentiles (see Figure 3B; WT dashed lines,
53–119 minutes, median 80 minutes, n ¼ 9; Csf1op/op solid
lines, 34–96 minutes, median 63, n ¼ 15). In the nondiabetic
mice in this study, the t1/2 values (mean ± SEM) for GE were
statistically signiﬁcantly lower in Csf1op/op mice compared
with WT (see Figure 3B; WT 86 ± 4.5 minutes, n ¼ 10; Op/Figure 3. Glucose levels and gastric emptying status in wild-
after induction of diabetes (Db). Data are represented as mean
.05, one-way ANOVA with Tukey’s post test). The circles repre
statistically signiﬁcantly higher in diabetic versus nondiabetic mic
same ﬁve groups of mice. The normal ranges for GE times (2.5t
mice as dotted lines and for Op/Op mice as solid lines. Data are re
way ANOVA), and circles represent individual animals. Statistic
versus nondiabetic WT, (b) versus nondiabetic Op/Op, (c) versus
Op. Age of mice: 12–14 weeks at the induction of diabetes, 20–
diabetic WT mice with delayed GE.Op 66.77 ± 5.37 minutes, n ¼ 15; P < .05, one-way ANOVA
with Tukey’s post-test). Despite severe diabetes, in Csf1op/op
mice the GE values remained in the normal range for up to
8 weeks after induction of diabetes and were not statisti-
cally signiﬁcantly different from the values obtained before
diabetes (see Figure 3B, op/op nondiabetic 66.77 ± 3.42;
op/op diabetic: 62.12 ± 1.82 minutes, P ¼ NS, one-way
ANOVA with Tukey’s post-test). In distinct contrast, 4 out
of 13 WT mice developed delayed GE at a mean of 6.25 ± 2.5
weeks after induction of diabetes as indicated by readings
outside the normal range (dashed lines) for WT nondiabetic
mice (see Figure 3B). This was statistically signiﬁcantly
different from the observation that no Csf1op/op mice had
delayed GE over the same period (P ¼ .03, Fisher’s exacttype (WT) Csf1D/D and Csf1op/op (Op/Op) mice before and
± standard error of the mean (SEM) of the grouped data (P <
sent individual animals. (A) As expected, glucose levels were
e, P < .05, n ¼ 5 mice/group. (B) Gastric emptying values in the
h to 97.5th percentiles) in nondiabetic mice are shown for WT
presented as mean ± SEM of the grouped data (P< .001, one-
al signiﬁcance (P < .05, Tukey’s post test) is indicated by (a)
diabetic WT with normal emptying, and (d) versus diabetic Op/
22 weeks for diabetic mice with normal GE, 16–22 weeks for
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betic (NOD) mice that developed delayed GE in our previous
studies.6 Diabetic WT Csf1þ/þ mice with delayed GE had
longer t1/2 values than the nondelayed diabetic WT Csf1
þ/þ,
nondiabetic WT Csf1þ/þ, and both diabetic and nondiabetic
Csf1op/op mice (see Figure 3B, WT diabetic with delayed GE;
154.9 ± 12.17 minutes; P < .05, one-way ANOVA with
Tukey’s post-test). These data are consistent with an
absence of macrophages resulting in resistance to devel-
opment of delayed GE in the cohort studied.
Previous work using NOD mice showed that oxidative
stress is elevated in diabetic NOD mice and further elevated
in diabetic NOD mice with delayed GE.6 MDA levels greater
than 80 nmol/mL were invariably associated with delayed
GE.6 In nondiabetic mice the levels of oxidative stress as
measured by plasma MDA levels (mean ± SEM) were not
different between Csf1op/op mice and WT Csf1þ/þ littermates
(Figure 4; WT nondiabetic 4.34 ± 1.30, Op/Op nondiabetic
10.03 ± 5.11 nmol/mL; n ¼ 5, P ¼ NS, one-way ANOVA with
Tukey’s post-test). After the onset of diabetes MDA levels
were statistically signiﬁcantly elevated in the Csf1op/op
compared with the Csf1þ/þ littermates (see Figure 4; Op/Op
diabetic with normal GE 75.8 ± 9.1 nmol/mL, WT diabetic
with normal GE 41.2 ± 13.6; n ¼ 5, P < .05, one-way ANOVA
with Tukey’s post-test). As previously reported for NOD
mice, development of delayed GE in WT, Csf1þ/þ wasFigure 4. Malondialdehyde levels were signiﬁcantly higher
in diabetic Csf1op/op (Op/Op) mice compared with diabetic
wild-type (WT) Csf1D/D mice with normal gastric
emptying (GE). Data are expressed as mean ± standard error
of the mean (SEM) (n ¼ 5 groups of mice). Malondialdehyde
levels were signiﬁcantly higher in WT with delayed GE (one-
way analysis of variance with Tukey’s post test). Data are
represented as mean ± SEM of the grouped data, and circles
represent individual animals. Signiﬁcance (P < .05) is indi-
cated by (a) versus nondiabetic WT, (b) versus nondiabetic
Op/Op, and (c) versus diabetic WT with normal GE (n ¼ 5).
Age of mice: 20–22 weeks.accompanied by increased levels of MDA (see Figure 4; WT
diabetic with delayed GE 102.5 ± 9.19 nmol/mL; n ¼ 5,
P < .05, one-way ANOVA with Tukey’s post-test). Despite
diabetic Csf1op/op mice all having normal GE, the MDA levels
were as high as those found in diabetic WT Csf1þ/þ mice
with delayed GE (see Figure 4; n ¼ 5, P ¼ NS, one-way
ANOVA with Tukey’s post-test).
Reduced Kit expression and impairment of ICC networks
in gastric muscularis propria are associated with develop-
ment of delayed GE and impairment of ICC networks in
diabetic mice.6 We measured the Kit mRNA levels by qRT-
PCR in gastric muscularis propria (Figure 5). Although
there was statistically signiﬁcant variation in the levels of
Kit mRNA from the tissues, there was no statistically sig-
niﬁcant difference in the Kit mRNA levels between Csf1op/op
and WT mice with normal GE whether diabetic or not dia-
betic (see Figure 5; WT nondiabetic 2.16 ± 0.87, Op/Op
nondiabetic 4.23 ± 2.45 fold change over actin; n ¼ 5,
P ¼ NS, one-way ANOVA with Tukey post-test). Diabetic WT
Csf1þ/þ mice with delayed GE had statistically signiﬁcantly
lower expression of Kit mRNA compared with diabetic WT
Csf1þ/þ mice with normal GE (P ¼ .03, t test), but this was
not statistically signiﬁcant for multiple comparisons (see
Figure 5; WT diabetic 2.12 ± 0.76; WT diabetic with delayed
GE 1.01 ± 0.19, fold change; n ¼ 5, P ¼ NS, one-way ANOVA
with Tukey post-test).
Damage to ICC networks is a common observation in mice
and humans with delayed GE.5,6,9 To determine whether
diabetic Csf1op/op mice had disrupted ICC networks evenFigure 5.Csf1op/op (Op/Op) and wild type (WT) Csf1D/D
mice express similar levels of Kit mRNA. Relative Kit
expression was statistically signiﬁcantly lower in diabetic WT
Csf1þ/þ mice with delayed gastric emptying (GE) compared
with diabetic WT Csf1þ/þ mice with normal GE (aP ¼ .03,
t test), but there were no statistically signiﬁcant differences
when correcting for multiple comparisons (one-way analysis
of variance, P ¼ NS). Data are mean ± standard error of the
mean; n ¼ 5 mice. Age of mice: 20–22 weeks.
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examined the ICC networks. There was no difference in
density of Kit-positive ICC between gastric muscularis
propria tissues from nondiabetic Csf1op/op mice (Figure 6B)
and tissues from Csf1op/op mice that had been diabetic for
more than 8 weeks (see Figure 6D), as scored by two inde-
pendent, blinded investigators (see Figure 6F; Op/Op
nondiabetic 6.06 ± 0.37, Op/Op diabetic 6.98 ± 0.14 density;
n ¼ 5, P ¼ NS, one-way ANOVA with Dunnett’s post-test). No
differences were also observed in ICC density between the
nondiabetic Csf1op/op mice (see Figure 6B) and the nondia-
betic WT (see Figure 6A) Csf1þ/þ (see Figure 6F; WT
nondiabetic 6.61 ± 0.32; n¼ 5, P¼ NS, one-way ANOVAwith
Dunnett’s post-test). However diabetic Csf1þ/þ mice that
developed delayed GE (see Figure 6E) had reduced ICC
density when compared with the diabetic Csf1þ/þ with
normal GE (see Figure 6D and F; WT diabetic with delayed GEFigure 6. Interstitial cells of Cajal (ICC) networks were not aff
of delayed gastric emptying (GE) in diabetic Csf1D/D was
immunoreactivity in the muscularis propria of the distal corpus
(WT) and Csf1op/op (B) Op/Op; in diabetic Csf1þ/þ (C) and Csf1o
GE (E) (age-matched/representative of n ¼ 3). Scale bar: 100 m
viation of the scores from biological replicates (n ¼ 3 mice; P <
Each circle represents the overall score from nine regions in ea
and nondiabetic Csf1op/op mice; 20–22 weeks for WT control; d
weeks old).5.71± 0.17, WT diabetic with normal GE 6.81± 0.04 density;
n ¼ 5, P < .005, one-way ANOVA with Dunnett’s post-test).Discussion
Our main and surprising ﬁnding was that diabetic
Csf1op/op mice do not develop delayed GE while their WT
siblings do. This suggests that macrophages are required for
the development of delayed GE in diabetes. We performed
this study because we previously had reported that
HO1-expressing, CD206-positive, alternatively activated
macrophages protected diabetic NOD mice from develop-
ment of delayed GE7 and that numbers of CD206-positive
macrophages correlate with ICC numbers in humans
with diabetic gastroparesis.14 We thus hypothesized that
depletion of macrophages—including, of course, M2 mac-
rophages—would lead to higher rates of delayed GE inected by diabetes in Csf1op/op mice while the development
associated with reduced density of ICC. Images of Kit
of the mouse stomach in nondiabetic Csf1þ/þ (A) wild type
p/op (D) with normal GE; and in diabetic Csf1þ/þ with delayed
m for each image. Whiskers show the mean ± standard de-
.05, one-way analysis of variance with Dunnett’s post test).
ch individual animal. Age of mice: 20–22 weeks for diabetic
iabetic Csf1þ/þ (WT) mice with delayed or normal GE (14–20
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esis that although M2 macrophages can protect gastric cell
types from injury, macrophages—likely M1 macrophages
releasing injurious proinﬂammatory cytokines—are
required to damage these key cell types, including ICC.
The protection of the diabetic Csf1op/op mice against
developing delayed GE occurred despite levels of oxidative
stress, elevated blood glucose, and dosing with insulin that
were not different from the WT siblings used in this study.
We also found that changes associated with delayed GE in
diabetic mice6 and humans,5,14 namely, disruption of ICC
networks and reduced expression of Kit, were not found in
the long-term diabetic Csf1op/op mice. Thus, it appears that
mechanisms that result in development of delayed GE in
diabetic mice on the time scale we studied are mediated
through a population of macrophages that are dependent on
Csf1 signaling. However this requires conﬁrmation by
testing the effect of populating the gastric muscularis
propria of diabetic Csf1op/op mice with macrophages.
We used Csf1op/op mice as we could not produce long-
term depletion of macrophages in diabetic mice either by
using clodronate liposomes as described by Van Rooijen
et al18 or by treating with diphtheria toxin in mice that
speciﬁcally express the diphtheria toxin receptor on CD11b-
positive macrophages.19 We found that clodronate lipo-
somes did not cause a sustained loss of macrophages, which
was required for our experiments, and the mice treated with
diphtheria toxin all died within 4 weeks (data not shown).
The Csf1op/op mouse does not express macrophages in
the lamina propria or the muscularis propria of the small
intestine,11,20 and we found that it does not express gastric
macrophages even when made diabetic. Csf1op/op mice have
signiﬁcant developmental problems that include failure to
develop teeth, skeletal abnormalities, and lower levels of
blood monocytes. Moreover, as elsewhere reported, they are
smaller in size when compared with age-matched WT lit-
termates. Despite this, with careful handling, the mice sur-
vived the induction of diabetes and survived to the end of
the 8 weeks of diabetes.
The Csf1op/op mice had low levels of plasma MDA com-
parable with the WT Csf1þ/þ littermates before induction of
diabetes and had signiﬁcantly higher levels after the onset of
diabetes. This is an observation that has not been previously
reported. Our study indicates that high oxidative stress as
indicated by oxidation of lipids and elevated MDA levels is
not sufﬁcient to cause cellular injury without macrophages.
A recent study21 has highlighted a role of resident
macrophages in regulating intestinal contractility through
an interaction with the enteric nervous system and the in-
testinal microbiome. It therefore appears that both resident
and activated macrophages have previously unknown roles
in modulating gastrointestinal motor function separate from
their known role in immunity. WT Csf1þ/þ mice behaved as
observed in other studies on NOD, C57Bl6, and BALB/c mice
(unpublished data)6,16 in that diabetic gastroparesis was
associated with higher levels of oxidative stress and that
decreased Kit expression is found in the diabetic mice that
develop delayed GE. The time course for development of
delayed GE (6.25 weeks after onset of diabetes) was similarto that found in NOD mice (5.5 weeks).6 Thus, it appears
that the streptozotocin-induced diabetic mouse model is
useful for studying mechanisms that might underlie diabetic
gastroparesis. Csf1op/op mice did have slightly but signiﬁ-
cantly faster GE than WT siblings before and after induction
of diabetes due to the inability of these animals to eat the
full 0.2 g meal. However, a consequence of the faster GE in
Csf1op/op mice was that the upper threshold for normal GE
was lower in mice after induction of diabetes compared
with WT mice but even that lower threshold was not
crossed with onset of diabetes. Thus, Csf1op/op mice repre-
sent a strain of mice that can be exploited to further
investigate the role of macrophages in diabetes-induced
tissue injury.
Our data strongly suggest that development of delayed
GE in diabetes requires the presence of muscle-layer mac-
rophages and that known mechanisms of injury in diabetes
appear to converge on macrophages. In particular,
M2 macrophages can protect gastric cells from injury, and
M1 macrophages are required to damage these key cells,
including ICC. In fact, despite the absence of M2 macro-
phages, the absence of injurious M1 cells during diabetes in
op/op mice results in no changes in ICC and therefore in the
absence of delay. Targeting macrophages may therefore be
an effective therapeutic option to prevent cellular damage
and the development of delayed GE in diabetes.References
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